⚡ Flash Summary

Abbott Laboratories (Pakistan) Limited has announced a board meeting to be held on October 29th, 2025, to consider the quarterly accounts for the period ending September 30th, 2025. In compliance with PSX Regulations, the company has declared a “Close Period” from October 22nd to October 29th, 2025, during which no Director, CEO, or Executive can deal in the company’s shares. The announcement was made to the Pakistan Stock Exchange, and TRE Certificate Holders of the Exchange are also to be informed.

📌 Key Takeaways

• 🗓️ Board meeting scheduled for October 29th, 2025.
• 🏢 Meeting to consider quarterly accounts ending September 30th, 2025.
• 🔒 “Close Period” declared from October 22nd to October 29th, 2025.
• 🚫 No trading by Directors, CEO, or Executives during the “Close Period”.
• 📜 Compliance with Clause 5.6.4 of PSX Regulations.
• 📢 Announcement to the Pakistan Stock Exchange.
• ✉️ TRE Certificate Holders to be informed.
• 📍 Abbott Laboratories (Pakistan) Limited is the reporting entity.
• 👤 Muhammad Usama Jamil is the Company Secretary.
• virtual meeting for quarterly results
• 🔒 no trading allowed for executives during the closed period

🎯 Investment Thesis

Given the lack of financial details in this announcement, a HOLD recommendation is appropriate. Awaiting the release of quarterly results is crucial to properly assess the company’s performance and revise the investment thesis accordingly. The board meeting will provide additional information.